Bin Zhu - Bridgewater NJ, US Joseph Wettstein - Lebanon NJ, US Margaret A. Petty - Bridgewater NJ, US
Assignee:
Aventis Pharmaceuticals Inc. - Bridgewater NJ
International Classification:
A61K 31/554
US Classification:
51421109, 5142111, 51421111, 51421112
Abstract:
The invention relates to the use of compound of Formula I in treating patients for inflammatory or neuropathic pain as well as various symptoms of multiple sclerosis.
Use Of (Z)-2-Cyano-3-Hydroxy-But-2-Enoic Acid-(4'-Trifluoromethylphenyl)-Amide For Treating Multiple Sclerosis
The invention relates to a method of treating multiple sclerosis by the use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4′-trifluoromethylphenyl)-amide in combination with another compound, which is effective in the treatment of multiple sclerosis.